| ObjectiveTo study therapeutical effect of ShenJiangTang on prematureventricualr beats(PVB) in patients suffering coronary heartdisease(CUD).Methods100 patients with PVB and GHD were randomly divided into 2 groups: thetreated group (n=50) and the control group (n=50). All patients weretreated with routine therapy, and the patients in treated group weretreated with ShenJiangTang 400ml/d (200ml po bid) additionally for 4 weekswhile the patients in control group were treated with amiodarone 0.6g/d(0.2 po tid) additionally for 4 weeks. At the end of 4 weeks, changes ofclinical syptoms and physical signs, blood-fat of patients in 2 groups wereobserved and compared.Result1. The therapeutic efficiency of clinical syptoms and physical signs: total effective rate is 88.8% in treated group(24 patiens improvedobviously, 20 patiens improved and 6 patiens got nothing changed), and incontrol group that is 90.0% (21 patiens improved obviously, 24 patiensimproved and 5 patiens got nothing changed). Statistically, the two groupshad no significant differences.2. Chinese medicine symptoms: the total effective rate is 98.8% intreated group(19 patiens cured, 15 patiens improved obviously, 14 patiensimproved and 2 patiens got nothing changed), and in control group that is92.0%(9 patiens cured, 16 patiens improved obviously, 17 patiens improvedand 8 patiens had no change).so, treated group is better than control groupon total effective rate.3. Comparement of PVB frequency in the 24-hour Holter monitoring: After treatment, the PVB frequency decreased in the patients of two groups, and there is no significant difference between the two groups.4. Blood-fat: TC and LDL-C change better in the treated group, but, inthe control group there is no change happened on TC and LDL-C.5. In this experiment, both of two groups have no adverse effect.ConclusionShen JiangTang is better than amiodarone on the therapeutic efficiencyof clinical syptoms and physical signs. Meanwhile, it makes patient'sBlood-fat change better. |
PDF Full Text Request